Log in to save to my catalogue

New Treatment Options and Management Considerations in Borderline Resectable Pancreatic Cancer

New Treatment Options and Management Considerations in Borderline Resectable Pancreatic Cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1910797465

New Treatment Options and Management Considerations in Borderline Resectable Pancreatic Cancer

About this item

Full title

New Treatment Options and Management Considerations in Borderline Resectable Pancreatic Cancer

Publisher

United States: UBM LLC

Journal title

Oncology (Williston Park, N.Y.), 2017-06, Vol.31 (6), p.443-452

Language

English

Formats

Publication information

Publisher

United States: UBM LLC

More information

Scope and Contents

Contents

In the United States, cancer of the pancreas accounts for nearly 40,000 deaths annually and is the fourth leading cause of cancer-related mortality. The vast majority of patients present with metastatic or unresectable disease. Only 20% of patients are candidates for surgery, and therefore curable. The 5-year survival rate for patients with pancrea...

Alternative Titles

Full title

New Treatment Options and Management Considerations in Borderline Resectable Pancreatic Cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1910797465

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1910797465

Other Identifiers

ISSN

0890-9091

How to access this item